| 1. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1149KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
New drug class for acid-related GI diseases |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 3-4
Tamara Schwarz,
Preview
|
PDF (2128KB)
|
|
摘要:
A new class of drugs, the reversible proton pump inhibitors, or so called acid pump antagonists (APAs), may prove to be a very useful addition to the physicians' armamentarium for treating patients with acid-related gastrointestinal (GI) diseases. In contrast to currently available proton pump inhibitors (PPIs), APAs interact with the gastric proton pump to give apparently complete acid inhibition in a reversible manner. The results of the first clinical study of Byk Gulden's newly developed APA BY-841*were presented at the 4th United European Gastroenterology Week [Berlin, Germany; September 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1085KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
Continued vigilance needed to prevent rheumatic fever outbreaks |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 5-5
&NA;,
Preview
|
PDF (1035KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1048KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 7-7
&NA;,
Preview
|
PDF (1063KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
2B1 may modulate tumour growth |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1070KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
Novel PDE IV inhibitors: exploring their potential in asthma |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 9-10
David B Jack,
Preview
|
PDF (2107KB)
|
|
摘要:
The enzyme phosphodiesterase (PDE) IV is a target for several companies seeking to develop innovative agents with both anti-asthmatic and anti-inflammatory properties. Several novel PDE IV inhibitors, such as RP-73401 [Rhône-Poulenc Rorer], CDP-840 [Celltech] and SB-207499 [SmithKline Beecham] are now in development. The most recent findings with these compounds were presented at the Second World Congress on Inflammation [Brighton, UK; September 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 10-10
&NA;,
Preview
|
PDF (1091KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
Negative preliminary results with ABT-200 for depression |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1012,
1995,
Page 11-11
&NA;,
Preview
|
PDF (989KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
